Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spectrum Pharma Inc (NQ: SPPI )

0.5692 -0.0158 (-2.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 873,056
Open 0.5800
Bid (Size) 0.5705 (15)
Ask (Size) 0.5950 (1)
Prev. Close 0.5850
Today's Range 0.5671 - 0.6088
52wk Range 0.3150 - 1.570
Shares Outstanding 164,071,943
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The 3 Best Biotech Stocks Under $1 to Buy for January
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff
From Spectrum Pharmaceuticals
Via Business Wire

Performance

YTD
+48.81%
+48.81%
1 Month
+77.88%
+77.88%
3 Month
+21.88%
+21.88%
6 Month
-29.99%
-29.99%
1 Year
-9.36%
-9.36%

More News

Read More
ROSEN, A LONGSTANDING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:SPPI Investor Alert: Lawsuit Alleges Misleading Statements by Spectrum Pharmaceuticals, Inc.
Via SBWire
ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI
From The Rosen Law Firm PA
Via Globe NewsWire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Spectrum Pharmaceuticals Announces Management Changes
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm– SPPI
From The Rosen Law Firm PA
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
SPPI EQUITY NOTICE: Rosen Law Firm Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
From The Rosen Law Firm, P.A.
Via Business Wire
Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Spectrum Pharmaceuticals, Inc.
From Robbins LLP
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Spectrum Pharmaceuticals, Inc. (SPPI)
From Robbins LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in Spectrum Pharmaceuticals, Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Spectrum Pharmaceuticals’ ROLVEDON™ (eflapegrastim-xnst) Injection Added to NCCN Supportive Care Guidelines in Oncology for Hematopoietic Growth Factors
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
From Spectrum Pharmaceuticals
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Spectrum, F45 Training, PROG, and Fox and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.